H.R. 275
IntroducedMedicare Prescription Drug Price Negotiation Act of 2019
Introduced 1/8/2019•116th Congress•House
Latest Action
Subcommittee Hearings Held.
9/25/2019 • House
Summary
Medicare Prescription Drug Price Negotiation Act of 2019
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Introduced in House • 1/8/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Health care costs and insuranceInflation and pricesMedicarePrescription drugsPublic contracts and procurement
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (38)
Party Breakdown
37
Democrats
1
Republicans
0
Independents
Sponsor
RL
Cosponsors (37)
R[
R[
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
January 8, 2019
Committee Review
September 25, 2019
Subcommittee Hearings Held.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House1/8/2019